Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

The Anti-Inflammatory Properties of Terpenoids from Cannabis.

Gallily R, Yekhtin Z, Hanuš LO.

Cannabis Cannabinoid Res. 2018 Dec 26;3(1):282-290. doi: 10.1089/can.2018.0014. eCollection 2018.

2.

Avidekel Cannabis extracts and cannabidiol are as efficient as Copaxone in suppressing EAE in SJL/J mice.

Gallily R, Yekhtin Z.

Inflammopharmacology. 2019 Feb;27(1):167-173. doi: 10.1007/s10787-018-0536-3. Epub 2018 Oct 5.

PMID:
30291491
3.

Indomethacin sensitizes resistant transformed cells to macrophage cytotoxicity.

Totary-Jain H, Sionov RV, Gallily R.

Immunol Lett. 2016 Aug;176:1-7. doi: 10.1016/j.imlet.2016.05.011. Epub 2016 May 17.

4.

In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma.

Fisher T, Golan H, Schiby G, PriChen S, Smoum R, Moshe I, Peshes-Yaloz N, Castiel A, Waldman D, Gallily R, Mechoulam R, Toren A.

Curr Oncol. 2016 Mar;23(2):S15-22. doi: 10.3747/co.23.2893. Epub 2016 Mar 16.

5.

HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid.

Haj CG, Sumariwalla PF, Hanuš L, Kogan NM, Yektin Z, Mechoulam R, Feldmann M, Gallily R.

J Pharmacol Exp Ther. 2015 Oct;355(1):66-75. doi: 10.1124/jpet.115.226100. Epub 2015 Aug 13.

6.

Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells.

Galanti G, Fisher T, Kventsel I, Shoham J, Gallily R, Mechoulam R, Lavie G, Amariglio N, Rechavi G, Toren A.

Acta Oncol. 2008;47(6):1062-70.

PMID:
17934890
7.

Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.

Durst R, Danenberg H, Gallily R, Mechoulam R, Meir K, Grad E, Beeri R, Pugatsch T, Tarsish E, Lotan C.

Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3602-7. Epub 2007 Sep 21.

8.

Cannabidiol arrests onset of autoimmune diabetes in NOD mice.

Weiss L, Zeira M, Reich S, Slavin S, Raz I, Mechoulam R, Gallily R.

Neuropharmacology. 2008 Jan;54(1):244-9. Epub 2007 Jul 17.

9.
10.

Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.

Weiss L, Zeira M, Reich S, Har-Noy M, Mechoulam R, Slavin S, Gallily R.

Autoimmunity. 2006 Mar;39(2):143-51.

PMID:
16698671
11.

A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells.

Kogan NM, Blázquez C, Alvarez L, Gallily R, Schlesinger M, Guzmán M, Mechoulam R.

Mol Pharmacol. 2006 Jul;70(1):51-9. Epub 2006 Mar 29.

PMID:
16571653
12.

N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties.

Milman G, Maor Y, Abu-Lafi S, Horowitz M, Gallily R, Batkai S, Mo FM, Offertaler L, Pacher P, Kunos G, Mechoulam R.

Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2428-33. Epub 2006 Feb 7.

13.

New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity.

Ben-Shabat S, Hanus LO, Katzavian G, Gallily R.

J Med Chem. 2006 Feb 9;49(3):1113-7.

PMID:
16451075
14.

The Jerusalem Balsam: from the Franciscan Monastery in the old city of Jerusalem to Martindale 33.

Moussaieff A, Fride E, Amar Z, Lev E, Steinberg D, Gallily R, Mechoulam R.

J Ethnopharmacol. 2005 Oct 3;101(1-3):16-26.

PMID:
15963667
15.

Dorzolamide-induced choroidal detachment in a surgically untreated eye.

Goldberg S, Gallily R, Bishara S, Blumenthal EZ.

Am J Ophthalmol. 2004 Aug;138(2):285-6.

PMID:
15289139
16.

A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis.

Sumariwalla PF, Gallily R, Tchilibon S, Fride E, Mechoulam R, Feldmann M.

Arthritis Rheum. 2004 Mar;50(3):985-98.

17.

Gamma-irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic cannabinoid, in cultured HL-60 myeloblastic leukemia cells.

Gallily R, Even-Chena T, Katzavian G, Lehmann D, Dagan A, Mechoulam R.

Leuk Lymphoma. 2003 Oct;44(10):1767-73.

PMID:
14692532
18.

Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model.

Lodzki M, Godin B, Rakou L, Mechoulam R, Gallily R, Touitou E.

J Control Release. 2003 Dec 12;93(3):377-87.

PMID:
14644587
19.

Cannabidiol: an overview of some pharmacological aspects.

Mechoulam R, Parker LA, Gallily R.

J Clin Pharmacol. 2002 Nov;42(S1):11S-19S. Review.

PMID:
12412831
20.

Effect of Mycoplasma fermentans on brain PGE(2): role of glucocorticoids and their receptors.

Wohlman A, Yirmiya R, Gallily R, Weidenfeld J.

Neuroimmunomodulation. 2001;9(3):141-7.

PMID:
11752887
21.

Inhibition of nitric oxide production for down-regulation of CNS inflammation and demyelination.

Brenner T, Pinto F, Abramsky O, Gallily R.

Prog Brain Res. 2001;132:499-506. Review. No abstract available.

PMID:
11545014
22.
23.

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.

Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M.

Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9561-6.

24.
25.

Antioxidants attenuate acute toxicity of tumor necrosis factor-alpha induced by brain injury in rat.

Trembovler V, Beit-Yannai E, Younis F, Gallily R, Horowitz M, Shohami E.

J Interferon Cytokine Res. 1999 Jul;19(7):791-5.

PMID:
10454350
26.

The role of brain cytokines in mediating the behavioral and neuroendocrine effects of intracerebral mycoplasma fermentans.

Yirmiya R, Weidenfeld J, Barak O, Avitsur R, Pollak Y, Gallily R, Wohlman A, Ovadia H, Ben-Hur T.

Brain Res. 1999 May 22;829(1-2):28-38.

PMID:
10350527
27.
28.

Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation.

Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M, Gallily R, Edwards CK 3rd, Schuchman EH, Fuks Z, Kolesnick R.

J Exp Med. 1997 Dec 1;186(11):1831-41.

29.

Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid.

Gallily R, Yamin A, Waksmann Y, Ovadia H, Weidenfeld J, Bar-Joseph A, Biegon A, Mechoulam R, Shohami E.

J Pharmacol Exp Ther. 1997 Nov;283(2):918-24.

PMID:
9353414
30.

Characterization of the effect of Mycoplasma fermentans on the hypothalamo-pituitary-adrenal axis.

Wohlman A, Gallily R, Yirmiya R, Weidenfeld J.

Neuroendocrinology. 1997 Sep;66(3):221-8.

PMID:
9380280
31.

Serotype-related differences in inflammatory response to Streptococcus pneumoniae in experimental meningitis.

Engelhard D, Pomeranz S, Gallily R, Strauss N, Tuomanen E.

J Infect Dis. 1997 Apr;175(4):979-82.

PMID:
9086164
32.

Intracerebral administration of Mycoplasma fermentans produces sickness behavior: role of prostaglandins.

Yirmiya R, Barak O, Avitsur R, Gallily R, Weidenfeld J.

Brain Res. 1997 Feb 21;749(1):71-81.

PMID:
9070629
33.

Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant.

Shohami E, Gallily R, Mechoulam R, Bass R, Ben-Hur T.

J Neuroimmunol. 1997 Feb;72(2):169-77. Review.

PMID:
9042110
34.

Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury.

Shohami E, Bass R, Wallach D, Yamin A, Gallily R.

J Cereb Blood Flow Metab. 1996 May;16(3):378-84.

PMID:
8621742
35.

Identification and characterization of a novel protein associated with macrophage complement receptor 3.

Messika EJ, Avni O, Gallily R, Yefenof E, Baniyash M.

J Immunol. 1995 Jun 15;154(12):6563-70.

PMID:
7759890
36.

Mycoplasma fermentans activates the hypothalamo-pituitary adrenal axis in the rat.

Weidenfeld J, Wohlman A, Gallily R.

Neuroreport. 1995 Apr 19;6(6):910-2.

PMID:
7612881
37.

Pasteurella multocida toxin induces IL-6, but not IL-1 alpha or TNF alpha in fibroblasts.

Rosendal S, Frandsen PL, Nielsen JP, Gallily R.

Can J Vet Res. 1995 Apr;59(2):154-6.

38.
39.

Cytokines induced in vitro by Mycoplasma mycoides ssp. mycoides, large colony type.

Rosendal S, Levisohn S, Gallily R.

Vet Immunol Immunopathol. 1995 Feb;44(3-4):269-78.

PMID:
7747406
40.

Differential H-2 antigen expression in teratocarcinoma-fibroblast hybrids.

Sionov RV, Gallily R.

Exp Clin Immunogenet. 1995;12(4):238-44.

PMID:
8919356
41.

Characterization and purification of a mycoplasma membrane-derived macrophage-activating factor.

Caplan S, Gallily R, Barenholz Y.

Cancer Immunol Immunother. 1994 Jul;39(1):27-33.

PMID:
8044823
42.

Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue.

Shohami E, Novikov M, Bass R, Yamin A, Gallily R.

J Cereb Blood Flow Metab. 1994 Jul;14(4):615-9.

PMID:
8014208
43.
44.

Trophoblasts protect the inner cell mass from macrophage destruction.

Sionov RV, Yagel S, Har-Nir R, Gallily R.

Biol Reprod. 1993 Sep;49(3):588-95.

PMID:
7691193
45.
46.

Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide.

Pappo I, Bercovier H, Berry EM, Haviv Y, Gallily R, Freund HR.

JPEN J Parenter Enteral Nutr. 1992 Nov-Dec;16(6):529-32.

PMID:
1494209
47.
49.
50.

Thymocyte maturation following interaction with thymus-derived macrophages.

Zeira M, Gallily R, Stein I, Giloh H.

Cell Immunol. 1991 May;134(2):370-7.

PMID:
1673640

Supplemental Content

Loading ...
Support Center